arrow
S

Stefan Macher

Medical University of Vienna
H指数:18
被引数:1,359

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cerebrospinal fluid protein elevations in Alzheimer's disease are dissociated from immune cell composition

阿尔茨海默病中脑脊液蛋白质升高与免疫细胞组成无关

2026-10-010
OAAI
Idiopathic Intracranial Hypertension Is Characterized by a Distinct Proteomic Profile

特发性颅内高压的特征是独特的蛋白质组学图谱

2026-05-280
OAAI
Epidemiology, pharmacological treatment and invasive management of idiopathic intracranial hypertension in Austria: a nationwide, hospital-based, controlled analysis of insurance data

特发性颅内高压的流行病学、药物治疗及侵入性管理在奥地利的现状:一项基于全国医院数据、对照分析的保险数据研究

2026-03-270
OAAI
Complications, outcomes, and implications of a prolonged vegetative state in anti-NMDA receptor encephalitis: a retrospective international cohort study

抗NMDA受体脑炎中持续植物状态并发症、结局及意义:一项国际回顾性队列研究

2026-03-180
PRE
Surgical Interventions in Idiopathic Intracranial Hypertension—A Comprehensive Multi-Center Study of Outcome and the Role of Treatment Indication

特发性颅内高压的手术治疗—一项关于结局和治疗适应证作用的多中心综合研究

2026-03-040
OAAI
Serum neurofilament light chain and glial fibrillary acidic protein levels are associated with inner retinal layer thinning in multiple sclerosis

血清神经丝轻链和胶质纤维酸性蛋白水平与多发性硬化中视网膜内层变薄相关

2025-08-190
OA
The rs10191329 Risk Allele Is Associated With Pronounced Retinal Layer Atrophy in Multiple Sclerosis

rs10191329风险等位基因与多发性硬化中明显的视网膜层萎缩相关。

2025-08-040
OAAI
Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical threshold
2024-12-160
OA
Neuropathological spectrum of anti-IgLON5 disease and stages of brainstem tau pathology: updated neuropathological research criteria of the disease-related tauopathy

anti-IgLON5疾病的神经病理谱和脑干tau病理分期: 疾病相关tau病的最新神经病理研究标准

2024-10-140
OAAI
Retinal layer thinning for monitoring disease-modifying treatment in relapsing multiple sclerosis-Evidence for applying a rebaselining concept
2024-08-071
PRE